The Prognostic Role of Decaf and Bap 65 Scores in Predicting Outcomes Among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Presenting to The Emergency Department of A Tertiary Care Centre In Chennai
Authors/Creators
- 1. International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Description
Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is characterized by persistent airflow limitation which is usually progressive and associated with enhanced chronic inflammatory response in the airways and lungs to noxious particles or gases. COPD is the fourth most frequent cause of death after ischemic heart disease, cerebrovascular disease and malignancy. COPD is a common cause of mortality and morbidity worldwide. Acute exacerbation of COPD is an acute event characterized by worsening of patient’s symptoms that is beyond normal day to day variation and leads to a change in medication. Exacerbations accelerate the rate of decline of lung function and are associated with significantly higher mortality.
Aim: To compare DECAF and BAP-65 SCORE in predicting the outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease.
Objective: To apply DECAF and BAP65 scoring systems on patients who present with acute exacerbation of COPD and to study the outcomes and to predict the better prognostic scoring system.
Expected Outcome and Benefit of Study: To identify high risk patient earlier with the better scoring system so as to assess the need for early intervention and easier risk stratisfication.
Methodology
Study Design: Hospital based prospective observational study.
Study Centre: ED, Government Stanley Medical College and Hospital.
Study Period: July 2021 to September 2022.
Study Population: Patients presenting to the emergency department with acute exacerbation of chronic obstructive pulmonary disease.
Result: A total of 130 patients were included in the study. The mortality rate was 58.8% (n=130). Mortality rates patients hospitalised with acute exacerbation of Chronic Obstructive Pulmonary Disease with DECAF scores > 3. The sensitivity of DECAF and BAP65 scores for prediction of mechanical ventilation need was 86.21% and 72.41%, respectively, whereas the specificity of was 68.32% and 31.68%, respectively, with 72.31% accuracy in DECAF score and 40.77% accuracy in BAP65 class. A positive significant correlation was found between DECAF score and BAP65 class (r=0.293, p=0.001).
Conclusion: In conclusion, a clinical prediction tool must be applicable, reliable, and beneficial. Both scores are practical in the sense that they can be easily calculated by asking simple questions and conducting routine laboratory tests.The BAP65 scoring system inculdes variable that are non invasive and quick to apply on a patient that is presenting to the ED, but it is also seen that its ease of use has not proven it to be a better scoring system in our analysis. In spite of the small sample size, DECAF score excels in predicting the mortality and the need for mechanical ventilation.
Files
REVATHI.pdf
Files
(1.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:45cad935a6f004b3d74d3eccaf144aa1
|
1.0 MB | Preview Download |
Additional details
Software
- Repository URL
- https://www.ijmacr.com/issue/archive_issue/56
References
- 1. O'Donnell DE, Parker CM. COPD exacerbations: pathophysiology. Thorax 2006;61:354–361. 2. Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001;134:600– 620. 3. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995;108:43S–52S. 4. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224–1238. 5. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S–9S. 6. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. Respir Care 2002;47:1184–1199. 7. Ramsey SD. Berry K. Etzioni R, Kaplan RM, Sullivan SD, Wood DE; National Emphysema Treatment Trial Group. Cost effectiveness of ung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092–2102. 8. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114–1121. 9. Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gilbert C. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990;142:1004–1008. 10. Monso´ E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316–1320. 11. J Steer, EM Norman, OA Afolali, GT Gibson, SC Bourke. Dysnea severity and Pneumonia as predictors of In-hospital mortality and early readmission in acute exacerbation of COPD. Thorax. 2012;67(2):117-121. 12. Gil H, Magy N, Mauny F, Dupond JL (2003) Value of eosinopenia in inflammatory disorders: an ''old'' marker revisited. Rev Med Interne 24: 431– 435. 13. Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, et al. (2011) Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 37: 1136–1142. 14. Shaaban H, Daniel S, Sison R, Slim J, Perez G (2010) Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care 25: 570– 575 15. Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M (2010) Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology 15: 165– 167. 16. Royal College of Physicians, British Thoracic Society, British Lung Foundation. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Clinical Audit of COPD Exacerbations Admitted to Acute NHS Trusts across the UK. London: Royal College of Physicians, 2008. 17. Davidson C. 2010 Adult Non-Invasive Ventilation Audit Summary Report. The British Thoracic Society, 2011. 18. Tabak YP, Sun X, Johannes RS, et al. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med 2009; 169:1595-602. 19. Hagaman JT, Rouan GW, Shipley RT, et al. Admission chest radiograph lacks sensitivity in the diagnosis of community-acquired pneumonia. Am J Med Sci 2009;337:236-40. 20. Roche N, Zureik M, Soussan D, et al. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008;32:953e61. 21. Thomas AJ, Valabhji P. Arrhythmia and tachycardia in pulmonary heart disease. Br Heart J 1969; 31: 491–495. 22. Lieberman D, Lieberman D, Gelfer Y, et al. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest 2002;122:1264e70. 23. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham Study. Am Heart J 1983; 105: 311–315. 24. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD – clinical practice guideline, part 1. Chest 2001; 119: 1185–1189. 25. Yan Cheng, Matthew E Borrego, Floyd J Frost, Hans Petersen and Dennis W Raisch. . Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease. SpringerPlus 2014, 3:359. 26. Steer, J., Gibson, J., & Bourke, S. C. (2012). The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax, 67(11), 970-976. 27. Sangwan, V., Chaudhry, D., & Malik, R. (2017). Dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score and BAP-65 score, tools for prediction of mortality in acute exacerbations of chronic obstructive pulmonary disease: a comparative pilot study. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 21(10), 671. 28. Zidan, M. H., Gharraf, H. S., & Wahdan, B. E. (2020). A comparative study of DECAF score and modified DECAF score in predicting hospital mortality rates in acute exacerbation of chronic obstructive pulmonary disease. The Egyptian Journal of Chest Diseases and Tuberculosis, 69(3), 532. 29. Manchu, D., & Sv, S. (2020). Prediction of Outcomes in Acute Exacerbation of COPD with Decaf Score and BAP 65 Scores in a Rural Population. The Journal of the Association of Physicians of India, 68(1), 80. 30. TelukuTla, S. R., VIdya, T., & GANESAN, N. (2020). BAP 65 and DECAF scores in Predicting Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Observational Study. Journal of Clinical & Diagnostic Research, 14(11).